文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Editorial: Urological cancer awareness month - 2022.

作者信息

Verras Georgios-Ioannis, Mulita Francesk

机构信息

General Surgery, Epsom and St. Helier University Hospitals, National Health Service (NHS) Trust, London, United Kingdom.

Department of Surgery, General University Hospital of Patras, Patras, Greece.

出版信息

Front Urol. 2024 May 20;4:1278688. doi: 10.3389/fruro.2024.1278688. eCollection 2024.

DOI:10.3389/fruro.2024.1278688
PMID:40777104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327328/
Abstract
摘要

相似文献

[1]
Editorial: Urological cancer awareness month - 2022.

Front Urol. 2024-5-20

[2]
Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.

Int J Urol. 2017-2

[3]
Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.

Cancer Res Treat. 2017-7

[4]
Value of routine renal and abdominal ultrasonography in patients undergoing prostatectomy.

Int Urol Nephrol. 2006

[5]
The bibliometric analysis of documents concerning the relationship between the microbiota and urological malignancies.

J Med Microbiol. 2025-7

[6]
Association between kidney stones and urological cancers: results from the NHANES 2007-2020 and Mendelian randomization study.

Discov Oncol. 2025-4-24

[7]
Loneliness, spiritual well-being, and death perception, as well as their risk factors in urological cancer patients.

Braz J Med Biol Res. 2023

[8]
Targeted Delivery of Therapeutics to Urological Cancer Stem Cells.

Curr Pharm Des. 2020

[9]
Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism.

Front Oncol. 2022-3-3

[10]
The spectrum of urological malignancy in Lynch syndrome.

Fam Cancer. 2013-3

本文引用的文献

[1]
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.

Nat Rev Clin Oncol. 2023-5

[2]
A Smarter Health through the Internet of Surgical Things.

Sensors (Basel). 2022-6-17

[3]
PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.

Cancer Treat Rev. 2022-3

[4]
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019.

Mil Med Res. 2021-11-24

[5]
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence.

Eur Urol Focus. 2022-3

[6]
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer.

JAMA Netw Open. 2021-3-1

[7]
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019.

Eur Urol. 2019-6-21

[8]
Urinary tract cancers: An overview for general practice.

J Family Med Prim Care. 2016

[9]
Contemporary bladder cancer: variant histology may be a significant driver of disease.

Urol Oncol. 2015-1

[10]
Antiproliferative effect of pHLIP-amanitin.

Biochemistry. 2013-2-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索